Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin

This article is cited by 10 publications.

1. Manfred Schlosser. Organoalkali Chemistry. 2013, 1-222. https://doi.org/10.1002/9781118484722.ch1
2. Donald W. Slocum. o -Lithioanisole. 2001https://doi.org/10.1002/047084289X.rl013
3. Hong Yu, Tommy Lewander. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat. European Neuropsychopharmacology 1997, 7 (3) , 165-172. https://doi.org/10.1016/S0924-977X(96)00395-1
4. Mark M. Foreman, Ray W. Fuller, J. David Leander, David L. Nelson, David O. Calligaro, Virginia L. Lucaites, David T. Wong, L. Zhang, James E. Barrett, John M. Schaus. Pharmacological characterization of enantiomers of 8‐thiomethyl‐2‐(di‐n‐propylamino)tetralin, potent and selective 5‐HT 1A receptor agonists. Drug Development Research 1995, 34 (1) , 66-85. https://doi.org/10.1002/ddr.430340110
5. Charles K.-F. Chiu. Alkenyl and Aryl Chalcogenides: Oxygen-based Functional Groups. 1995, 635-703. https://doi.org/10.1016/B0-08-044705-8/00267-3
6. . References to Volume 2. 1995, 1103-1295. https://doi.org/10.1016/B0-08-044705-8/09010-5
7. J. P. Mason, J. Caldwell, L. G. Dring. Metabolism of [propyl- 3 H]-8-hydroxy-2-(N,N-di-n-propylamino)tetralin in rat. Xenobiotica 1995, 25 (1) , 71-80. https://doi.org/10.3109/00498259509061834
8. B Backlund Höök, H Yu, T Mezei, L Björk, B Svensson, NE Andén, U Hacksell. Tricyclic non-phenolic derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin: stereoselective interactions with 5-HT1A receptors in the brain. European Journal of Medicinal Chemistry 1991, 26 (2) , 215-220. https://doi.org/10.1016/0223-5234(91)90032-I
9. Philip J. Dudfield. Vinylic and Arylic CH Oxidation. 1991, 329-343. https://doi.org/10.1016/B978-0-08-052349-1.00193-1
10. James S. New, Katherine S. Takaki. Chapter 1. Antipsychotic Agents. 1989, 1-10. https://doi.org/10.1016/S0065-7743(08)60523-0